Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication.
about
Recent developments in antiviral agents against enterovirus 71 infectionTherapeutic and prevention strategies against human enterovirus 71 infectionAnti-enterovirus 71 effects of chrysin and its phosphate esterManagement of Viral Central Nervous System Infections: A Primer for CliniciansRibavirin suppresses bacterial virulence by targeting LysR-type transcriptional regulatorsAnimal models of enterovirus 71 infection: applications and limitations.Changes of circulating Th22 cells in children with hand, foot, and mouth disease caused by enterovirus 71 infectionInhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1.Quinacrine impairs enterovirus 71 RNA replication by preventing binding of polypyrimidine-tract binding protein with internal ribosome entry sites.Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71Genetic diversity of a Korean echovirus 5 isolate and response of the strain to five antiviral drugs.Enterovirus infections of the central nervous system.Resveratrol inhibits enterovirus 71 replication and pro-inflammatory cytokine secretion in rhabdosarcoma cells through blocking IKKs/NF-κB signaling pathway.Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-acting factorsLycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replicationAntiviral Potential of a Novel Compound CW-33 against Enterovirus A71 via Inhibition of Viral 2A Protease.A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infectionMolecular characterization and antiviral activity test of common drugs against echovirus 18 isolated in Korea.Studies on Inhibition of Proliferation of Enterovirus-71 by Compound YZ-LY-0.Necrotizing myositis causes restrictive hypoventilation in a mouse model for human enterovirus 71 infectionHuman enterovirus 71 epidemics: what's next?Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads.Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71.Development of antiviral agents for enteroviruses.Human enterovirus 71 and hand, foot and mouth disease.Tranylcypromine reduces herpes simplex virus 1 infection in mice.The need for treatment against human parechoviruses: how, why and when?The virology and developments toward control of human enterovirus 71.Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management.Enteroviral encephalitis in children: clinical features, pathophysiology, and treatment advances.Understanding Enterovirus 71 Neuropathogenesis and Its Impact on Other Neurotropic Enteroviruses.Adoptive transfer of macrophages from adult mice reduces mortality in mice infected with human enterovirus 71.CD4 T-cell-independent antibody response reduces enterovirus 71 lethality in mice by decreasing tissue viral loads.In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection.Enterovirus 71 infection of human dendritic cells.Clinical features and management outcomes of severe hand, foot and mouth disease.Discovery of gramine derivatives that inhibit the early stage of EV71 replication in vitro.Enterovirus 71: epidemiology, pathogenesis and management.Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice.Isochlorogenic acid C prevents enterovirus 71 infection via modulating redox homeostasis of glutathione.
P2860
Q26849627-DA293297-DE08-4988-B883-1F34B896EF40Q28080796-16ABBCFC-DBBC-4345-AE23-463809E914D6Q28540436-E2F5534B-B4CB-4268-95B3-F58B21088188Q30145523-5E98E5E2-4FD8-49EC-90AC-6E8498BE94A1Q30832528-93F8AEC5-DEFE-4378-B925-F20C521F6193Q33579809-477419EF-5DD0-47B0-AC27-33DACE5808D6Q33710131-3F55BCB3-83C0-494E-A9C9-B1E04C18CFABQ34259967-4DF9D4B2-843E-45AB-804F-1D782CB95C2AQ34542235-2CFAB854-980E-4202-A3D7-C123C8180173Q34593800-A75C4DD2-9550-4B5E-8654-4B1B840BA2A7Q34677656-B4698110-13C3-43E6-B828-C673E8761277Q34697319-8687A7D2-871E-464D-92FB-BDE21B03EC8AQ35097865-E605C590-6D24-4288-A617-6C95C7A75984Q35351497-47FC87E1-FC05-46D4-97B0-33DD5F333F7CQ35540385-BAB07235-D9D0-4CE1-B581-E2914847C994Q35808685-41186B2A-032A-49B2-8834-1E85BC45B4E0Q35826494-BF150958-0C06-4132-9043-A320C87EB2E1Q36041320-985CB6D6-6646-4F5C-96F1-8A07D6AAD568Q36274964-CF187045-81F5-4481-8636-78B97AD582E9Q37008702-01264427-9EDF-4021-BBE1-4243A2E3A822Q37168703-BB8D221E-1F97-47ED-80C5-B0698632AABBQ37232853-E4116486-3EB5-454A-9389-18BF3BA400B4Q37247709-D2F0E738-6343-4246-8FF6-7EE07049AA57Q37302641-D7310010-DB0C-4877-8708-0420FBBF1A46Q37670343-4ABDAFB5-8C7B-439D-ABB3-545D93CA46BEQ37712992-2172FE6F-9525-4FE8-8CC5-31436F333681Q37816394-6411437A-D509-4207-A4CB-656F06C2E6C4Q37886179-DD7003F8-4012-488C-8007-2A37B8DE8A92Q38078826-65FA0A73-8BEC-4BFB-B46D-0E311F277387Q38245116-51E2B461-86C0-4ECA-8954-B1C0E4738FD2Q38567118-0B7B9ECB-21C3-4825-8F4F-F5FEAA465E4DQ39240063-EEEC035A-6E86-4732-B473-F355E7DE54BAQ39248462-907B2E9A-C807-46CC-B3E5-63D16F519DEDQ39412134-2113422C-4F67-47BA-9115-2ECD7A1FED81Q39825846-12746E78-ECE6-4296-B27C-F69173FBACAFQ40301917-11672E31-FF58-4435-8459-AB98CB911A99Q42209155-5979689F-CF7D-451D-9E23-FE5948650B96Q43291847-08EEE5E1-18CB-4063-8830-9217D87BAB68Q44444682-EC7E3C25-2478-4478-AF9F-71B4AE507007Q46254128-D450698D-09D8-4955-B906-67FDE9EB67DD
P2860
Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Ribavirin reduces mortality in ...... decreasing viral replication.
@ast
Ribavirin reduces mortality in ...... decreasing viral replication.
@en
Ribavirin reduces mortality in ...... decreasing viral replication.
@nl
type
label
Ribavirin reduces mortality in ...... decreasing viral replication.
@ast
Ribavirin reduces mortality in ...... decreasing viral replication.
@en
Ribavirin reduces mortality in ...... decreasing viral replication.
@nl
prefLabel
Ribavirin reduces mortality in ...... decreasing viral replication.
@ast
Ribavirin reduces mortality in ...... decreasing viral replication.
@en
Ribavirin reduces mortality in ...... decreasing viral replication.
@nl
P2093
P2860
P356
P1476
Ribavirin reduces mortality in ...... decreasing viral replication.
@en
P2093
Chien-Ming Li
Ching-Chuan Liu
Chun-Keung Yu
Fang-Hsiu Shen
Shih-Heng Chen
Shun-Hua Chen
Zhao-Hong Li
P2860
P304
P356
10.1086/527326
P407
P577
2008-03-01T00:00:00Z